株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

無侵襲的出生前検査の世界市場:用途別(トリソミー、ターナー症候群、Rh式血液型など)、製品別、技術別、エンドユーザー別、地域別の予測と機会

Global Non-invasive Prenatal Testing Market By Application (Trisomy, Turner syndrome, Rh Blood type and Others), By Product, By Technology, By End User, By Region, Forecast & Opportunities, 2025

発行 TechSci Research 商品コード 934728
出版日 ページ情報 英文 111 Pages
納期: お問合せ
価格
本日の銀行送金レート: 1USD=109.72円で換算しております。

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

無侵襲的出生前検査の世界市場:用途別(トリソミー、ターナー症候群、Rh式血液型など)、製品別、技術別、エンドユーザー別、地域別の予測と機会 Global Non-invasive Prenatal Testing Market By Application (Trisomy, Turner syndrome, Rh Blood type and Others), By Product, By Technology, By End User, By Region, Forecast & Opportunities, 2025
出版日: 2020年05月01日 ページ情報: 英文 111 Pages
概要

無侵襲的出生前検査(NIPT)は、技術の進歩や母親の出産年齢上昇に加え、ダウン症候群、エドワーズ症候群、パトー症候群などの遺伝性疾患の増加といった要因を背景に世界規模で実施件数が増加しています。現在最大の市場となっているのは、政府が多額の資金を投入している北米地域ですが、出生前検査に対する意識が高まりつつあるアジア太平洋地域の市場も今後急速に成長すると見られています。

当レポートは、世界のNIPT市場を調査したもので、新型コロナウイルス感染症(COVID-19)が市場に及ぼす影響、各地域市場の展望、市場の力学と動向、競合状況と主要企業のプロファイルなどの情報に加え、戦略的提言も示しています。

目次

第1章 製品の概要

第2章 調査方法

第3章 世界の無侵襲的出生前検査(NIPT)市場に対するCOVID-19の影響

第4章 エグゼクティブサマリー

第5章 世界市場の展望

  • 市場規模と予測
    • 金額ベースと数量ベース
  • 市場シェアと予測
    • 用途別(トリソミー(ダウン症候群、エドワーズ症候群、パトー症候群)、ターナー症候群、Rh式血液型など)
    • 製品別(機器、キット、アッセイ)
    • 技術別(セルフリー胎児DNA検査、超並列シーケンス、ターゲットキャプチャーシーケンスなど)
    • エンドユーザー(病院、診断検査室)
    • 企業別(2019年)
    • 地域別
  • 市場魅力指数

第6章 アジア太平洋市場の展望

  • 市場規模と予測
    • 金額ベースと数量ベース
  • 市場シェアと予測
    • 用途別
    • 製品別
    • 技術別
    • エンドユーザー別
    • 国別
  • 市場魅力指数
  • アジア太平洋:国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • シンガポール
    • オーストラリア

第7章 欧州市場の展望

  • 市場規模と予測
    • 金額ベースと数量ベース
  • 市場シェアと予測
    • 用途別
    • 製品別
    • 技術別
    • エンドユーザー別
    • 国別
  • 市場魅力指数
  • 欧州:国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア

第8章 北米市場の展望

  • 市場規模と予測
    • 金額ベースと数量ベース
  • 市場シェアと予測
    • 用途別
    • 製品別
    • 技術別
    • エンドユーザー別
    • 国別
  • 市場魅力指数
  • 北米:国別分析
    • 米国
    • メキシコ
    • カナダ

第9章 南米市場の展望

  • 市場規模と予測
    • 金額ベースと数量ベース
  • 市場シェアと予測
    • 用途別
    • 製品別
    • 技術別
    • エンドユーザー別
    • 国別
  • 市場魅力指数
  • 南米:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカ市場の展望

  • 市場規模と予測
    • 金額ベースと数量ベース
  • 市場シェアと予測
    • 用途別
    • 製品別
    • 技術別
    • エンドユーザー別
    • 国別
  • 市場魅力指数
  • 中東・アフリカ:国別分析
    • 南アフリカ
    • サウジアラビア
    • UAE

第11章 市場の力学

  • 促進促進要因
  • 課題

第12章 市場の動向

第13章 競合情勢

  • 競合情勢の展望
  • 主要企業のプロファイル
    • Roche
    • Integrated Genetics
    • Natera
    • BGI Genomics
    • Illumina
    • Invitae
    • Genesis Genomics
    • PerkinElmer
    • Eurofins Scientific
    • Thermo Fisher Scientific
    • Agilent Technologies
    • Yourgene Health
    • Berry Genomics
    • Igenomix
    • Quest Diagnostics
    • Asper Biogene
    • Myriad Genetics
    • Progenity
    • Fasteris
    • Bionet Corp.

第14章 戦略的提言

第15章 免責事項

目次
Product Code: 4669

Global non-invasive prenatal testing (NIPT) market is expected to witness a robust growth during the forecast period. Increasing genetic disorders in pre-borne children and growing population are the major factors for the growth of the market. Additionally, rise in maternal age and technology advancement have also boosted the demand of NIPT solutions as parents wants to ensure that their baby is free from all disorders and earlier diagnosis assist in that. However, high maintenance and lack of competent professionals are major factors restraining the growth of the market across the globe.

The global non-invasive prenatal testing (NIPT) market is segmented based on application, product, technology, end user and region. The application segment is further segmented into trisomy, turner syndrome, Rh blood type and others, out of which trisomy held the dominant share in 2019 due to the increasing prevalence of Down's syndrome, Edward's syndrome and Patau syndromes in unborn children.

In terms of regional analysis, North America led the market in 2019. The factors responsible for the dominance of North America include heavy funding by the government and presence of leading market players in the region. On the other hand, Asia-Pacific is anticipated to grow at the fastest rate in the coming years due to increasing awareness about prenatal testing among population.

Leading players in the global non-invasive prenatal testing (NIPT) market include Roche, Integrated Genetics, Natera, BGI Genomics, Illumina, Invitae, Genesis Genomics, PerkinElmer, Eurofins Scientific, Thermo Fisher Scientific, Agilent Technologies, Yourgene Health, Berry Genomics, Igenomix, Quest Diagnostics, Asper Biogene, Myriad Genetics, Progenity, Fasteris, Bionet Corp, etc. In order to maintain their position in the market and to generate large revenues, leading players tend to adopt various organic and inorganic strategies like mergers and acquisitions.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and forecast the market size of global non-invasive prenatal testing (NIPT) market.
  • To classify and forecast global non-invasive prenatal testing (NIPT) market based on application, product, technology, end user and region and company.
  • To identify drivers and challenges for global non-invasive prenatal testing (NIPT) market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global non-invasive prenatal testing (NIPT) market.
  • To conduct pricing analysis for global non-invasive prenatal testing (NIPT) market.
  • To identify and analyze the profile of leading players operating in global non-invasive prenatal testing (NIPT) market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals and clinics performing non-invasive prenatal testing across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals and clinics performing non-invasive prenatal testing which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals and clinics performing non-invasive prenatal testing and presence of all major players across the globe.

TechSci Research calculated the market size of global non-invasive prenatal testing (NIPT) market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Non-invasive prenatal testing (NIPT) hospitals, clinics and laboratories and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to non-invasive prenatal testing (NIPT)
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals and clinics performing non-invasive prenatal testing, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global non-invasive prenatal testing (NIPT) market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Application:

Trisomy (Down Syndrome, Edwards Syndrome, Patau Syndrome)

Turner Syndrome

Rh Blood Type

Others

  • Market, By Product:

Instruments

Kits

Assay

  • Market, By Technology:

Cell Free Fetal DNA Technology

Massively Parallel Sequencing

Target Capture Sequences Technology

Others

  • Market, By End User:

Hospitals

Diagnostic Laboratory

  • Market, By Region:

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Singapore
  • Australia

Europe

  • France
  • Germany
  • United Kingdom
  • Italy

North America

  • United States
  • Mexico
  • Canada

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global non-invasive prenatal testing (NIPT) market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Non-Invasive Prenatal Testing (NIPT) Market

4. Executive Summary

5. Global Non-Invasive Prenatal Testing (NIPT) Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Trisomy (Down Syndrome, Edwards Syndrome, Patau Syndrome), Turner Syndrome, Rh Blood Type and Others)
    • 5.2.2. By Products (Instruments, Kits and Assay)
    • 5.2.3. By Technology (Cell Free Fetal DNA Technology, Massively Parallel Sequencing, Target Capture Sequences Technology and Others)
    • 5.2.4. By End-User (Hospitals and Diagnostic Laboratory)
    • 5.2.5. By Company (2019)
    • 5.2.6. By Region
  • 5.3. Market Attractiveness Index

6. Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Products
    • 6.2.3. By Technology
    • 6.2.4. By End-User
    • 6.2.5. By Country
  • 6.3. Market Attractiveness Index
  • 6.4. Asia-Pacific: Country Analysis
    • 6.4.1. China Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 6.4.1.1. Market Size & Forecast
        • 6.4.1.1.1. By Value
      • 6.4.1.2. Market Share & Forecast
        • 6.4.1.2.1. By Application
        • 6.4.1.2.2. By Products
        • 6.4.1.2.3. By Technology
        • 6.4.1.2.4. By End-User
    • 6.4.2. India Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 6.4.2.1. Market Size & Forecast
        • 6.4.2.1.1. By Value
      • 6.4.2.2. Market Share & Forecast
        • 6.4.2.2.1. By Application
        • 6.4.2.2.2. By Products
        • 6.4.2.2.3. By Technology
        • 6.4.2.2.4. By End-User
    • 6.4.3. Japan Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 6.4.3.1. Market Size & Forecast
        • 6.4.3.1.1. By Value
      • 6.4.3.2. Market Share & Forecast
        • 6.4.3.2.1. By Application
        • 6.4.3.2.2. By Products
        • 6.4.3.2.3. By Technology
        • 6.4.3.2.4. By End-User
    • 6.4.4. South Korea Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 6.4.4.1. Market Size & Forecast
        • 6.4.4.1.1. By Value
      • 6.4.4.2. Market Share & Forecast
        • 6.4.4.2.1. By Application
        • 6.4.4.2.2. By Products
        • 6.4.4.2.3. By Technology
        • 6.4.4.2.4. By End-User
    • 6.4.5. Singapore Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 6.4.5.1. Market Size & Forecast
        • 6.4.5.1.1. By Value
      • 6.4.5.2. Market Share & Forecast
        • 6.4.5.2.1. By Application
        • 6.4.5.2.2. By Products
        • 6.4.5.2.3. By Technology
        • 6.4.5.2.4. By End-User
    • 6.4.6. Australia Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 6.4.6.1. Market Size & Forecast
        • 6.4.6.1.1. By Value
      • 6.4.6.2. Market Share & Forecast
        • 6.4.6.2.1. By Application
        • 6.4.6.2.2. By Products
        • 6.4.6.2.3. By Technology
        • 6.4.6.2.4. By End-User

7. Europe Non-Invasive Prenatal Testing (NIPT) Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Products
    • 7.2.3. By Technology
    • 7.2.4. By End-User
    • 7.2.5. By Country
  • 7.3. Market Attractiveness Index
  • 7.4. Europe: Country Analysis
    • 7.4.1. France Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 7.4.1.1. Market Size & Forecast
        • 7.4.1.1.1. By Value
      • 7.4.1.2. Market Share & Forecast
        • 7.4.1.2.1. By Application
        • 7.4.1.2.2. By Products
        • 7.4.1.2.3. By Technology
        • 7.4.1.2.4. By End-User
    • 7.4.2. Germany Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 7.4.2.1. Market Size & Forecast
        • 7.4.2.1.1. By Value
      • 7.4.2.2. Market Share & Forecast
        • 7.4.2.2.1. By Application
        • 7.4.2.2.2. By Products
        • 7.4.2.2.3. By Technology
        • 7.4.2.2.4. By End-User
    • 7.4.3. United Kingdom Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 7.4.3.1. Market Size & Forecast
        • 7.4.3.1.1. By Value
      • 7.4.3.2. Market Share & Forecast
        • 7.4.3.2.1. By Application
        • 7.4.3.2.2. By Products
        • 7.4.3.2.3. By Technology
        • 7.4.3.2.4. By End-User
    • 7.4.4. Italy Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 7.4.4.1. Market Size & Forecast
        • 7.4.4.1.1. By Value
      • 7.4.4.2. Market Share & Forecast
        • 7.4.4.2.1. By Application
        • 7.4.4.2.2. By Products
        • 7.4.4.2.3. By Technology
        • 7.4.4.2.4. By End-User

8. North America Non-Invasive Prenatal Testing (NIPT) Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Products
    • 8.2.3. By Technology
    • 8.2.4. By End-User
    • 8.2.5. By Country
  • 8.3. Market Attractiveness Index
  • 8.4. North America: Country Analysis
    • 8.4.1. United States Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Application
        • 8.4.1.2.2. By Products
        • 8.4.1.2.3. By Technology
        • 8.4.1.2.4. By End-User
    • 8.4.2. Mexico Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Application
        • 8.4.2.2.2. By Products
        • 8.4.2.2.3. By Technology
        • 8.4.2.2.4. By End-User
    • 8.4.3. Canada Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Application
        • 8.4.3.2.2. By Products
        • 8.4.3.2.3. By Technology
        • 8.4.3.2.4. By End-User

9. South America Non-Invasive Prenatal Testing (NIPT) Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Products
    • 9.2.3. By Technology
    • 9.2.4. By End-User
    • 9.2.5. By Country
  • 9.3. Market Attractiveness Index
  • 9.4. South America: Country Analysis
    • 9.4.1. Brazil Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Application
        • 9.4.1.2.2. By Products
        • 9.4.1.2.3. By Technology
        • 9.4.1.2.4. By End-User
    • 9.4.2. Argentina Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Application
        • 9.4.2.2.2. By Products
        • 9.4.2.2.3. By Technology
        • 9.4.2.2.4. By End-User
    • 9.4.3. Colombia Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 9.4.3.1. Market Size & Forecast
        • 9.4.3.1.1. By Value
      • 9.4.3.2. Market Share & Forecast
        • 9.4.3.2.1. By Application
        • 9.4.3.2.2. By Products
        • 9.4.3.2.3. By Technology
        • 9.4.3.2.4. By End-User

10. Middle East and Africa Non-Invasive Prenatal Testing (NIPT) Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Products
    • 10.2.3. By Technology
    • 10.2.4. By End-User
    • 10.2.5. By Country
  • 10.3. Market Attractiveness Index
  • 10.4. MEA: Country Analysis
    • 10.4.1. South Africa Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 10.4.1.1. Market Size & Forecast
        • 10.4.1.1.1. By Value
      • 10.4.1.2. Market Share & Forecast
        • 10.4.1.2.1. By Application
        • 10.4.1.2.2. By Products
        • 10.4.1.2.3. By Technology
        • 10.4.1.2.4. By End-User
    • 10.4.2. Saudi Arabia Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 10.4.2.1. Market Size & Forecast
        • 10.4.2.1.1. By Value
      • 10.4.2.2. Market Share & Forecast
        • 10.4.2.2.1. By Application
        • 10.4.2.2.2. By Products
        • 10.4.2.2.3. By Technology
        • 10.4.2.2.4. By End-User
    • 10.4.3. UAE Non-Invasive Prenatal Testing (NIPT) Market Outlook
      • 10.4.3.1. Market Size & Forecast
        • 10.4.3.1.1. By Value
      • 10.4.3.2. Market Share & Forecast
        • 10.4.3.2.1. By Application
        • 10.4.3.2.2. By Products
        • 10.4.3.2.3. By Technology
        • 10.4.3.2.4. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

  • 13.1. Competition Outlook
  • 13.2. Players Profiled (Leading Companies)
    • 13.2.1. Roche
    • 13.2.2. Integrated Genetics
    • 13.2.3. Natera
    • 13.2.4. BGI Genomics
    • 13.2.5. Illumina
    • 13.2.6. Invitae
    • 13.2.7. Genesis Genomics
    • 13.2.8. PerkinElmer
    • 13.2.9. Eurofins Scientific
    • 13.2.10. Thermo Fisher Scientific
    • 13.2.11. Agilent Technologies
    • 13.2.12. Yourgene Health
    • 13.2.13. Berry Genomics
    • 13.2.14. Igenomix
    • 13.2.15. Quest Diagnostics
    • 13.2.16. Asper Biogene
    • 13.2.17. Myriad Genetics
    • 13.2.18. Progenity
    • 13.2.19. Fasteris
    • 13.2.20. Bionet Corp.

14. Strategic Recommendations

15. About Us & Disclaimer